July 2014
|Volume 14 Issue 7
Editorial Staff
Clinical EditorBradley Knight, MD
Executive Editor
Laurie Gustafson
Managing Editor
Jodie Elrod
Production Manager
Alexa Flinn
Editorial Correspondence
Jodie Elrod, Managing Editor, EP Lab DigestHMP Communications, 70 E. Swedesford Rd
Suite 100, Malvern PA 19355
Telephone: (800) 371-0791
Fax: (866) 488-8273
Email: jelrod@hmpglobal.com
Included is an overview of the upcoming meeting, which will be held August 16-17 at the Sheraton Crown Center in Kansas City, Missouri.
Linda Moulton, RN, MS contributes a review of the highlights and major changes seen in the new guidelines for the management of patients with atrial fibrillation.
Adel Mina, MD, FACC and Nicholas Warnecke, PA-C stress that cases must be individualized when it comes to stroke risk reduction prior to pursuing direct current cardioversion and/or ablation.
James Kneller, MD, MSc, PhD, FHRS, CCDS shares his workflow for CFE-guided PVI and AF ablation, which he anticipates will improve outcomes.
The LAPTOP-HF study is (was) a prospective, multi-center, IDE trial that involved placement of a left atrial pressure (LAP) transducer.
Mary P. Orencole, MS, ANP-BC and colleagues provide information on MADIT-CHIC, the first prospective study of the cardiac resynchronization therapy defibrillator (CRT-D) in chemotherapy-induced cardiomyopathy.
Luann Hallahan, RN, BSN, BC presents a study that was done to determine if a single, dedicated EP lab at UPMC Passavant Hospital could improve its TAT efficiency to compare to the Operating Room TAT national average of 20-25 minutes.
This month we check out the EP program in Pensacola, Florida.
Senthil Thambidorai, MD, FHRS details a case from the Memorial Hermann The Woodlands, a community-based hospital that recently performed their first S-ICD implantation.
Daniel S. Goldman, MD, FACC, FHRS and Linda Moulton, RN, MSN describe a new “non-invasive” device for skin closure that was recently approved for low-tension surgical wounds.